Shares were mixed in Asia on Tuesday after Wall Street held near its records, with traders awaiting fresh cues about interest ...

The Little Mix singer said she auditioned for "The X Factor" just months after leaving the hospital, where she was treated ...

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

(Reuters) -Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying ...

Novo Nordisk (NYSE:NVO) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts. On August 15, Novo ...

FDA has approved Novo Nordisk's Wegovy, one-weekly 2.4 mg semaglutide injection for treating metabolic-associated ...

The clinical-stage biotech, closely watched by some because of its investigational weight-loss drug VK2735, saw its share ...

Dow Jones Top Company Headlines at 9 PM ET: SoftBank Invests $2 Billion in Intel as U.S. Considers Taking 10% Stake in Chip Maker | BHP ... SoftBank Invests $2 Billion in Intel as U.S. Considers ...

Viking Therapeutics offers a speculative opportunity, driven by its promising obesity drug pipeline. Click here to read more ...

The detention facility operator named Patrick Swindle as its next chief executive officer, succeeding long-time executive Damon Hininger, who will continue at the company under a transition agreement.

Interestingly, Wall Street firms largely believe the former will playout in the long run. According to The Wall Street ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...